Hypoxia-Inducible Factor-1α Expression in Macrophages Promotes Development of Atherosclerosis
OBJECTIVE—Atherosclerotic lesions contain hypoxic areas, but the pathophysiological importance of hypoxia is unknown. Hypoxia-inducible factor-1α (HIF-1α) is a key transcription factor in cellular responses to hypoxia. We investigated the hypothesis that HIF-1α has effects on macrophage biology that...
Saved in:
Published in | Arteriosclerosis, thrombosis, and vascular biology Vol. 36; no. 9; pp. 1782 - 1790 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
American Heart Association, Inc
01.09.2016
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | OBJECTIVE—Atherosclerotic lesions contain hypoxic areas, but the pathophysiological importance of hypoxia is unknown. Hypoxia-inducible factor-1α (HIF-1α) is a key transcription factor in cellular responses to hypoxia. We investigated the hypothesis that HIF-1α has effects on macrophage biology that promotes atherogenesis in mice.
APPROACH AND RESULTS—Studies with molecular probes, immunostaining, and laser microdissection of aortas revealed abundant hypoxic, HIF-1α–expressing macrophages in murine atherosclerotic lesions. To investigate the significance of macrophage HIF-1α, Ldlr mice were transplanted with bone marrow from mice with HIF-1α deficiency in the myeloid cells or control bone marrow. The HIF-1α deficiency in myeloid cells reduced atherosclerosis in aorta of the Ldlr recipient mice by ≈72% (P=0.006).In vitro, HIF-1α–deficient macrophages displayed decreased differentiation to proinflammatory M1 macrophages and reduced expression of inflammatory genes. HIF-1α deficiency also affected glucose uptake, apoptosis, and migratory abilities of the macrophages.
CONCLUSIONS—HIF-1α expression in macrophages affects their intrinsic inflammatory profile and promotes development of atherosclerosis. |
---|---|
AbstractList | OBJECTIVE—Atherosclerotic lesions contain hypoxic areas, but the pathophysiological importance of hypoxia is unknown. Hypoxia-inducible factor-1α (HIF-1α) is a key transcription factor in cellular responses to hypoxia. We investigated the hypothesis that HIF-1α has effects on macrophage biology that promotes atherogenesis in mice.
APPROACH AND RESULTS—Studies with molecular probes, immunostaining, and laser microdissection of aortas revealed abundant hypoxic, HIF-1α–expressing macrophages in murine atherosclerotic lesions. To investigate the significance of macrophage HIF-1α, Ldlr mice were transplanted with bone marrow from mice with HIF-1α deficiency in the myeloid cells or control bone marrow. The HIF-1α deficiency in myeloid cells reduced atherosclerosis in aorta of the Ldlr recipient mice by ≈72% (P=0.006).In vitro, HIF-1α–deficient macrophages displayed decreased differentiation to proinflammatory M1 macrophages and reduced expression of inflammatory genes. HIF-1α deficiency also affected glucose uptake, apoptosis, and migratory abilities of the macrophages.
CONCLUSIONS—HIF-1α expression in macrophages affects their intrinsic inflammatory profile and promotes development of atherosclerosis. OBJECTIVEAtherosclerotic lesions contain hypoxic areas, but the pathophysiological importance of hypoxia is unknown. Hypoxia-inducible factor-1α (HIF-1α) is a key transcription factor in cellular responses to hypoxia. We investigated the hypothesis that HIF-1α has effects on macrophage biology that promotes atherogenesis in mice.APPROACH AND RESULTSStudies with molecular probes, immunostaining, and laser microdissection of aortas revealed abundant hypoxic, HIF-1α-expressing macrophages in murine atherosclerotic lesions. To investigate the significance of macrophage HIF-1α, Ldlr(-/-) mice were transplanted with bone marrow from mice with HIF-1α deficiency in the myeloid cells or control bone marrow. The HIF-1α deficiency in myeloid cells reduced atherosclerosis in aorta of the Ldlr(-/-) recipient mice by ≈72% (P=0.006).In vitro, HIF-1α-deficient macrophages displayed decreased differentiation to proinflammatory M1 macrophages and reduced expression of inflammatory genes. HIF-1α deficiency also affected glucose uptake, apoptosis, and migratory abilities of the macrophages.CONCLUSIONSHIF-1α expression in macrophages affects their intrinsic inflammatory profile and promotes development of atherosclerosis. Atherosclerotic lesions contain hypoxic areas, but the pathophysiological importance of hypoxia is unknown. Hypoxia-inducible factor-1α (HIF-1α) is a key transcription factor in cellular responses to hypoxia. We investigated the hypothesis that HIF-1α has effects on macrophage biology that promotes atherogenesis in mice. Studies with molecular probes, immunostaining, and laser microdissection of aortas revealed abundant hypoxic, HIF-1α-expressing macrophages in murine atherosclerotic lesions. To investigate the significance of macrophage HIF-1α, Ldlr(-/-) mice were transplanted with bone marrow from mice with HIF-1α deficiency in the myeloid cells or control bone marrow. The HIF-1α deficiency in myeloid cells reduced atherosclerosis in aorta of the Ldlr(-/-) recipient mice by ≈72% (P=0.006).In vitro, HIF-1α-deficient macrophages displayed decreased differentiation to proinflammatory M1 macrophages and reduced expression of inflammatory genes. HIF-1α deficiency also affected glucose uptake, apoptosis, and migratory abilities of the macrophages. HIF-1α expression in macrophages affects their intrinsic inflammatory profile and promotes development of atherosclerosis. Objective— Atherosclerotic lesions contain hypoxic areas, but the pathophysiological importance of hypoxia is unknown. Hypoxia-inducible factor-1α (HIF-1α) is a key transcription factor in cellular responses to hypoxia. We investigated the hypothesis that HIF-1α has effects on macrophage biology that promotes atherogenesis in mice. Approach and Results— Studies with molecular probes, immunostaining, and laser microdissection of aortas revealed abundant hypoxic, HIF-1α–expressing macrophages in murine atherosclerotic lesions. To investigate the significance of macrophage HIF-1α, Ldlr −/− mice were transplanted with bone marrow from mice with HIF-1α deficiency in the myeloid cells or control bone marrow. The HIF-1α deficiency in myeloid cells reduced atherosclerosis in aorta of the Ldlr −/− recipient mice by ≈72% ( P =0.006). In vitro, HIF-1α–deficient macrophages displayed decreased differentiation to proinflammatory M1 macrophages and reduced expression of inflammatory genes. HIF-1α deficiency also affected glucose uptake, apoptosis, and migratory abilities of the macrophages. Conclusions— HIF-1α expression in macrophages affects their intrinsic inflammatory profile and promotes development of atherosclerosis. |
Author | Junker, Nanna Christoffersen, Christina Aarup, Annemarie Nielsen, Carsten H Nielsen, Lars B Pedersen, Tanja X Bartels, Emil D Madsen, Marie |
AuthorAffiliation | From the Department of Biomedical Sciences (A.A., T.X.P., N.J., C.C., M.M., C.H.N., L.B.N.) and Department of Clinical Medicine (L.B.N.), University of Copenhagen, Denmark; and Department of Clinical Biochemistry, Rigshospitalet, Copenhagen University Hospital, Denmark (C.C., E.D.B., L.B.N.) |
AuthorAffiliation_xml | – name: From the Department of Biomedical Sciences (A.A., T.X.P., N.J., C.C., M.M., C.H.N., L.B.N.) and Department of Clinical Medicine (L.B.N.), University of Copenhagen, Denmark; and Department of Clinical Biochemistry, Rigshospitalet, Copenhagen University Hospital, Denmark (C.C., E.D.B., L.B.N.) |
Author_xml | – sequence: 1 givenname: Annemarie surname: Aarup fullname: Aarup, Annemarie organization: From the Department of Biomedical Sciences (A.A., T.X.P., N.J., C.C., M.M., C.H.N., L.B.N.) and Department of Clinical Medicine (L.B.N.), University of Copenhagen, Denmark; and Department of Clinical Biochemistry, Rigshospitalet, Copenhagen University Hospital, Denmark (C.C., E.D.B., L.B.N.) – sequence: 2 givenname: Tanja surname: Pedersen middlename: X fullname: Pedersen, Tanja X – sequence: 3 givenname: Nanna surname: Junker fullname: Junker, Nanna – sequence: 4 givenname: Christina surname: Christoffersen fullname: Christoffersen, Christina – sequence: 5 givenname: Emil surname: Bartels middlename: D fullname: Bartels, Emil D – sequence: 6 givenname: Marie surname: Madsen fullname: Madsen, Marie – sequence: 7 givenname: Carsten surname: Nielsen middlename: H fullname: Nielsen, Carsten H – sequence: 8 givenname: Lars surname: Nielsen middlename: B fullname: Nielsen, Lars B |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/27444197$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kM1OwkAUhScGIz_6Ai5Ml26K88dMWVYEIcHogri0mba3Up126kwr8Fi-iM9kCejSzb33JOec5H591ClNCQhdEjwkRJCbcPV8G87DvRgyLAOGT1CPjCj3uWCi095Yjv2R4LSL-s69YYw5pfgMdanknJOx7KGX-a4y21z5izJtkjzW4M1UUhvrk-8vb7qtLDiXm9LLS-9BJdZUa_UKznuypjB1e9zBJ2hTFVDWnsm8sF6DNS7R-5m7c3SaKe3g4rgHaDWbriZzf_l4v5iESz9heIz9keSMKJECDiRXlMeUpjEEUggmRxlTqcwCqWKeyCwWFDIWcAkExywjQaJSNkDXh9rKmo8GXB0VuUtAa1WCaVxEAsKFaEHg1koP1vYX5yxkUWXzQtldRHC0xxodse5FdMDahq6O_U1cQPoX-eXYGsTBsDG6BuvedbMBG61B6Xr9X_MPqkuIKQ |
CitedBy_id | crossref_primary_10_1111_1755_5922_12262 crossref_primary_10_1002_advs_202207224 crossref_primary_10_1111_jcmm_13977 crossref_primary_10_1016_j_jacbts_2020_05_006 crossref_primary_10_1016_j_cmet_2017_06_001 crossref_primary_10_1016_j_biopha_2020_110338 crossref_primary_10_1016_j_mce_2020_110878 crossref_primary_10_1161_CIRCRESAHA_123_324086 crossref_primary_10_3390_biomedicines8110470 crossref_primary_10_1016_j_bioactmat_2020_09_005 crossref_primary_10_5483_BMBRep_2019_52_6_140 crossref_primary_10_1016_j_jacbts_2019_10_007 crossref_primary_10_1161_ATVBAHA_119_313290 crossref_primary_10_1016_j_pharmthera_2017_09_003 crossref_primary_10_1038_s41590_018_0113_3 crossref_primary_10_3390_ijms24010589 crossref_primary_10_1038_s41423_021_00791_9 crossref_primary_10_1186_s12974_023_02793_y crossref_primary_10_1016_j_tips_2019_02_004 crossref_primary_10_1096_fj_202302001R crossref_primary_10_1038_s41419_020_03372_2 crossref_primary_10_1186_s12967_017_1336_z crossref_primary_10_3390_cells9020336 crossref_primary_10_1186_s13020_022_00658_9 crossref_primary_10_1084_jem_20200667 crossref_primary_10_1007_s10456_021_09816_3 crossref_primary_10_1007_s00109_018_1710_1 crossref_primary_10_1161_CIRCRESAHA_119_315939 crossref_primary_10_1172_JCI137557 crossref_primary_10_20900_immunometab20210017 crossref_primary_10_1007_s40620_022_01432_8 crossref_primary_10_3389_fimmu_2019_02951 crossref_primary_10_1016_j_redox_2022_102504 crossref_primary_10_3390_cells9010195 crossref_primary_10_1161_ATVBAHA_120_314037 crossref_primary_10_1096_fj_202201486R crossref_primary_10_1016_j_semnephrol_2018_02_006 crossref_primary_10_3390_ijtm1010004 crossref_primary_10_3390_ijms242115866 crossref_primary_10_1097_MOL_0000000000000550 crossref_primary_10_1536_ihj_21_233 crossref_primary_10_3390_ijms22168992 crossref_primary_10_1038_s41392_023_01652_9 crossref_primary_10_1016_j_molimm_2022_06_003 crossref_primary_10_1152_ajprenal_00418_2017 crossref_primary_10_1016_j_cdtm_2021_05_001 crossref_primary_10_1002_adtp_202100232 crossref_primary_10_1016_j_jpha_2023_11_016 crossref_primary_10_1016_j_mam_2020_100922 crossref_primary_10_1016_j_ccl_2021_04_003 crossref_primary_10_2967_jnumed_120_245407 crossref_primary_10_1016_j_intimp_2021_108413 crossref_primary_10_1038_s44161_024_00473_5 crossref_primary_10_3389_fimmu_2022_868958 crossref_primary_10_1039_D2TB00811D crossref_primary_10_1161_JAHA_123_033109 crossref_primary_10_1016_j_intimp_2023_110305 crossref_primary_10_1080_17435390_2021_1917716 crossref_primary_10_1080_14740338_2023_2285889 crossref_primary_10_3390_antiox11112183 crossref_primary_10_1007_s00395_018_0686_x crossref_primary_10_3390_cells11162586 crossref_primary_10_1080_17435390_2022_2083995 crossref_primary_10_1024_0301_1526_a001044 crossref_primary_10_1111_odi_13856 crossref_primary_10_1002_iub_2667 crossref_primary_10_1016_j_ejphar_2017_09_012 crossref_primary_10_1161_ATVBAHA_118_311806 crossref_primary_10_1016_j_biopha_2023_114333 crossref_primary_10_1097_MOL_0000000000000539 crossref_primary_10_1016_j_phrs_2022_106081 crossref_primary_10_3389_fimmu_2024_1402468 crossref_primary_10_3390_biomedicines11061734 crossref_primary_10_1093_cvr_cvab152 crossref_primary_10_1038_s41419_023_06206_z crossref_primary_10_1016_j_intimp_2019_106150 crossref_primary_10_1073_pnas_1618411114 crossref_primary_10_3390_biomedicines9040328 crossref_primary_10_1161_ATVBAHA_119_312287 crossref_primary_10_1016_j_heliyon_2023_e17167 crossref_primary_10_1016_j_cca_2022_07_004 crossref_primary_10_3390_jcm11216465 crossref_primary_10_1038_s41598_017_06816_6 crossref_primary_10_1016_j_ejphar_2017_04_028 crossref_primary_10_1007_s00281_017_0656_7 crossref_primary_10_1111_imr_13214 crossref_primary_10_1007_s00424_017_1941_y crossref_primary_10_1016_j_cyto_2018_02_002 crossref_primary_10_1093_cvr_cvz107 crossref_primary_10_4049_jimmunol_2300293 crossref_primary_10_1097_MOL_0000000000000634 crossref_primary_10_1016_j_surg_2016_11_009 crossref_primary_10_1038_s41467_022_32871_3 crossref_primary_10_1038_s41598_020_77793_6 crossref_primary_10_3390_ijms231911488 crossref_primary_10_1161_ATVBAHA_117_309228 crossref_primary_10_1007_s11882_019_0871_5 crossref_primary_10_1177_1708538120904297 crossref_primary_10_20900_immunometab20200028 crossref_primary_10_1016_j_arr_2023_101993 crossref_primary_10_4103_MJ_MJ_12_19 crossref_primary_10_1097_MCA_0000000000001142 crossref_primary_10_1002_1873_3468_12786 |
Cites_doi | 10.1161/ATVBAHA.108.183319 10.1161/ATVBAHA.115.305551 10.1073/pnas.0403259101 10.1038/35017054 10.1161/ATVBAHA.115.307136 10.1007/s007950200023 10.1681/ASN.2014111139 10.1038/ncpcardio1247 10.1016/j.atherosclerosis.2007.05.026 10.1074/jbc.M113.522037 10.1161/01.ATV.7.3.238 10.1172/JCI23865 10.1093/ndt/gfv302 10.1038/cdd.2008.12 10.1016/S1471-4914(01)02090-1 10.1073/pnas.0511043103 10.4049/jimmunol.165.6.3430 10.1681/ASN.2015030241 10.1016/S0368-1319(69)80005-0 10.1073/pnas.92.12.5510 10.1136/jclinpath-2012-200828 10.1161/ATVBAHA.115.306171 10.1182/blood.V94.5.1561 10.1097/MOL.0b013e3283307be8 10.1161/CIRCRESAHA.111.246363 10.1042/bj3500307 10.7326/0003-4819-71-2-426 10.4049/jimmunol.178.12.7516 10.1161/01.ATV.17.11.2479 10.1146/annurev.immunol.021908.132532 10.1016/j.jacc.2007.12.025 10.1096/fj.13-235911 10.1038/20459 10.1016/S0006-2952(02)01155-3 10.1126/science.1059817 10.1038/nm1102-1235 10.1073/pnas.080072497 10.2741/3168 10.1038/nature10146 10.1016/S0368-1319(69)80023-2 10.1016/0021-9150(72)90051-2 10.1038/nature01323 10.1038/35025220 10.1038/nrc1187 10.1189/jlb.0908536 10.1016/j.ejphar.2007.01.066 10.1182/blood-2002-09-2711 10.1161/JAHA.114.001232 10.1194/jlr.M050633 10.1016/0021-9150(73)90027-0 10.1161/ATVBAHA.115.306861 10.1016/j.cardiores.2006.09.005 10.1016/S0092-8674(03)00154-5 10.1097/MOL.0b013e32833ded6a 10.3171/JNS/2008/109/7/0083 10.1074/jbc.272.36.22642 10.1194/jlr.R800032-JLR200 10.1161/ATVBAHA.111.235788 10.1002/jcb.25074 10.1161/01.ATV.19.4.870 10.1093/emboj/19.16.4298 10.1161/ATVBAHA.110.221440 10.1016/S0021-9258(17)31580-6 10.3758/BRM.40.3.879 10.1161/01.ATV.0000184783.04864.9f 10.1038/bjc.1995.429 10.1016/j.jacc.2011.03.044 |
ContentType | Journal Article |
Copyright | 2016 American Heart Association, Inc. |
Copyright_xml | – notice: 2016 American Heart Association, Inc. |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 |
DOI | 10.1161/ATVBAHA.116.307830 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE CrossRef |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1524-4636 |
EndPage | 1790 |
ExternalDocumentID | 10_1161_ATVBAHA_116_307830 27444197 10.1161/ATVBAHA.116.307830 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | - .Z2 01R 08R 0R 1J1 23N 2WC 3O- 40H 4Q1 4Q2 4Q3 53G 55 5GY 5RE 5VS 71W 77Y 7O 7O~ AAAXR AAMOA AAMTA AAPBV AARTV AAXQO ABBUW ABXVJ ABZAD ACDDN ACEWG ACGFS ACGOD ACPRK ACWDW ACWRI ACXNZ ADACO ADBBV ADFPA ADNKB AE3 AENEX AFFNX AFUWQ AHMBA AHULI AHVBC AIJEX AJIOK AJNYG AJYGW ALMA_UNASSIGNED_HOLDINGS AMJPA ASCII AWKKM BAWUL BOYCO C1A C45 CS3 DIK DUNZO E.X E3Z EBS EJD EX3 F2K F2L F2M F2N F5P FL- FRP FW0 GJ GX1 H0 H0~ H13 HZ IKYAY IN IN~ J5H JF9 JG8 JK3 JK8 K8S KD2 KMI KQ8 L-C L7B LI0 N9A N~7 N~B N~M O0- O9- OAG OAH OB2 OCUKA ODA OHASI OK1 OL1 OLG OLH OLU OLV OLW OLY OLZ OPUJH ORVUJ OUVQU OVD OVDNE OVIDH OVLEI OWW OWY OXXIT P-K P2P PQEST PQQKQ PZZ RAH RHF RIG RLZ RSW S4R S4S V2I WOQ WOW X3V X3W X7M Z2 ZA5 ZGI --- .3C .55 .GJ 0R~ AAAAV AAGIX AAHPQ AAIQE AAQKA AASCR AASOK ABASU ABDIG ABJNI ABQRW ABVCZ ACCJW ACILI ACLDA ACXJB ADGGA ADHPY AE6 AEETU AFDTB AGINI AHJKT AHOMT AHQNM AHRYX AINUH AJNWD AJZMW AKULP ALMTX AMKUR AMNEI AOHHW AYCSE BQLVK BS7 CGR CUY CVF DIWNM ECM EEVPB EIF ERAAH FCALG GNXGY GQDEL HLJTE HZ~ IKREB IPNFZ NPM OWU OWV OWX OWZ T8P TEORI TR2 TSPGW VVN W3M W8F XXN XYM YFH ZZMQN AAYXX CITATION 7X8 |
ID | FETCH-LOGICAL-c3090-57431a6de0874a24b22dbe8766375f3ad7f87ab4c7fb62ef3847e10b3f18cad3 |
ISSN | 1079-5642 |
IngestDate | Sat Oct 26 00:39:44 EDT 2024 Fri Aug 23 01:19:02 EDT 2024 Wed Oct 16 00:59:07 EDT 2024 Thu Aug 13 19:46:46 EDT 2020 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 9 |
Keywords | atherosclerosis hypoxia-inducible factor 1α hypoxia apoptosis macrophage |
Language | English |
License | 2016 American Heart Association, Inc. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c3090-57431a6de0874a24b22dbe8766375f3ad7f87ab4c7fb62ef3847e10b3f18cad3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://www.ahajournals.org/doi/pdf/10.1161/ATVBAHA.116.307830 |
PMID | 27444197 |
PQID | 1814666420 |
PQPubID | 23479 |
PageCount | 9 |
ParticipantIDs | proquest_miscellaneous_1814666420 crossref_primary_10_1161_ATVBAHA_116_307830 pubmed_primary_27444197 wolterskluwer_health_10_1161_ATVBAHA_116_307830 |
ProviderPackageCode | L-C C45 7O~ AARTV ADFPA OLH ASCII OLG AAMOA ODA ABZAD ABBUW JK3 ADNKB JK8 H0~ 1J1 OLV OLU JG8 OLW OLZ OLY F2K F2M F2L F2N OHASI AHVBC AJNYG FL- KMI K8S OVLEI AJIOK OPUJH V2I S4R S4S 4Q1 DUNZO OAG 4Q2 OVDNE 4Q3 AMJPA OAH OVD 71W AHULI OB2 ACEWG .Z2 N~7 IKYAY OVIDH AWKKM 40H N~B OUVQU ORVUJ X3V X3W ACDDN ACWRI BOYCO AIJEX AAXQO AAMTA AAAXR E.X OWW OCUKA OWY 01R ACXNZ OL1 ABXVJ IN~ KD2 OXXIT 77Y ACWDW JF9 FW0 |
PublicationCentury | 2000 |
PublicationDate | 2016-September 2016-09-00 20160901 |
PublicationDateYYYYMMDD | 2016-09-01 |
PublicationDate_xml | – month: 09 year: 2016 text: 2016-September |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Arteriosclerosis, thrombosis, and vascular biology |
PublicationTitleAlternate | Arterioscler Thromb Vasc Biol |
PublicationYear | 2016 |
Publisher | American Heart Association, Inc |
Publisher_xml | – name: American Heart Association, Inc |
References | e_1_3_5_27_2 e_1_3_5_25_2 e_1_3_5_23_2 e_1_3_5_21_2 e_1_3_5_44_2 e_1_3_5_65_2 e_1_3_5_46_2 e_1_3_5_67_2 e_1_3_5_48_2 e_1_3_5_69_2 e_1_3_5_29_2 e_1_3_5_40_2 e_1_3_5_61_2 e_1_3_5_42_2 e_1_3_5_63_2 e_1_3_5_7_2 e_1_3_5_9_2 e_1_3_5_3_2 e_1_3_5_5_2 e_1_3_5_39_2 e_1_3_5_16_2 e_1_3_5_37_2 e_1_3_5_14_2 e_1_3_5_12_2 e_1_3_5_35_2 e_1_3_5_10_2 e_1_3_5_33_2 e_1_3_5_54_2 e_1_3_5_56_2 e_1_3_5_58_2 e_1_3_5_18_2 e_1_3_5_50_2 Mendis S (e_1_3_5_2_2) 2011 e_1_3_5_52_2 e_1_3_5_31_2 e_1_3_5_28_2 e_1_3_5_26_2 e_1_3_5_24_2 e_1_3_5_22_2 e_1_3_5_43_2 e_1_3_5_66_2 e_1_3_5_45_2 e_1_3_5_68_2 e_1_3_5_47_2 e_1_3_5_49_2 e_1_3_5_60_2 e_1_3_5_62_2 e_1_3_5_41_2 e_1_3_5_64_2 e_1_3_5_8_2 e_1_3_5_20_2 e_1_3_5_4_2 e_1_3_5_6_2 e_1_3_5_17_2 e_1_3_5_38_2 e_1_3_5_15_2 e_1_3_5_36_2 e_1_3_5_13_2 e_1_3_5_34_2 e_1_3_5_11_2 e_1_3_5_32_2 e_1_3_5_55_2 e_1_3_5_57_2 e_1_3_5_59_2 e_1_3_5_19_2 e_1_3_5_51_2 e_1_3_5_53_2 e_1_3_5_30_2 |
References_xml | – ident: e_1_3_5_36_2 doi: 10.1161/ATVBAHA.108.183319 – ident: e_1_3_5_63_2 doi: 10.1161/ATVBAHA.115.305551 – ident: e_1_3_5_53_2 doi: 10.1073/pnas.0403259101 – ident: e_1_3_5_25_2 doi: 10.1038/35017054 – ident: e_1_3_5_47_2 doi: 10.1161/ATVBAHA.115.307136 – ident: e_1_3_5_4_2 doi: 10.1007/s007950200023 – ident: e_1_3_5_67_2 doi: 10.1681/ASN.2014111139 – ident: e_1_3_5_3_2 doi: 10.1038/ncpcardio1247 – ident: e_1_3_5_39_2 doi: 10.1016/j.atherosclerosis.2007.05.026 – ident: e_1_3_5_62_2 doi: 10.1074/jbc.M113.522037 – ident: e_1_3_5_17_2 doi: 10.1161/01.ATV.7.3.238 – ident: e_1_3_5_35_2 doi: 10.1172/JCI23865 – ident: e_1_3_5_69_2 doi: 10.1093/ndt/gfv302 – ident: e_1_3_5_28_2 doi: 10.1038/cdd.2008.12 – ident: e_1_3_5_19_2 doi: 10.1016/S1471-4914(01)02090-1 – ident: e_1_3_5_54_2 doi: 10.1073/pnas.0511043103 – ident: e_1_3_5_65_2 doi: 10.4049/jimmunol.165.6.3430 – ident: e_1_3_5_68_2 doi: 10.1681/ASN.2015030241 – ident: e_1_3_5_44_2 doi: 10.1016/S0368-1319(69)80005-0 – ident: e_1_3_5_20_2 doi: 10.1073/pnas.92.12.5510 – ident: e_1_3_5_29_2 doi: 10.1136/jclinpath-2012-200828 – ident: e_1_3_5_46_2 doi: 10.1161/ATVBAHA.115.306171 – ident: e_1_3_5_57_2 doi: 10.1182/blood.V94.5.1561 – ident: e_1_3_5_11_2 doi: 10.1097/MOL.0b013e3283307be8 – ident: e_1_3_5_31_2 doi: 10.1161/CIRCRESAHA.111.246363 – ident: e_1_3_5_58_2 doi: 10.1042/bj3500307 – ident: e_1_3_5_12_2 doi: 10.7326/0003-4819-71-2-426 – ident: e_1_3_5_34_2 doi: 10.4049/jimmunol.178.12.7516 – ident: e_1_3_5_64_2 doi: 10.1161/01.ATV.17.11.2479 – ident: e_1_3_5_66_2 doi: 10.1146/annurev.immunol.021908.132532 – ident: e_1_3_5_15_2 doi: 10.1016/j.jacc.2007.12.025 – ident: e_1_3_5_6_2 doi: 10.1096/fj.13-235911 – ident: e_1_3_5_24_2 doi: 10.1038/20459 – ident: e_1_3_5_51_2 doi: 10.1016/S0006-2952(02)01155-3 – ident: e_1_3_5_23_2 doi: 10.1126/science.1059817 – ident: e_1_3_5_10_2 doi: 10.1038/nm1102-1235 – ident: e_1_3_5_26_2 doi: 10.1073/pnas.080072497 – ident: e_1_3_5_40_2 doi: 10.2741/3168 – ident: e_1_3_5_9_2 doi: 10.1038/nature10146 – ident: e_1_3_5_13_2 doi: 10.1016/S0368-1319(69)80023-2 – ident: e_1_3_5_18_2 doi: 10.1016/0021-9150(72)90051-2 – ident: e_1_3_5_5_2 doi: 10.1038/nature01323 – ident: e_1_3_5_14_2 doi: 10.1038/35025220 – ident: e_1_3_5_21_2 doi: 10.1038/nrc1187 – ident: e_1_3_5_55_2 doi: 10.1189/jlb.0908536 – ident: e_1_3_5_30_2 doi: 10.1016/j.ejphar.2007.01.066 – ident: e_1_3_5_56_2 doi: 10.1182/blood-2002-09-2711 – ident: e_1_3_5_8_2 doi: 10.1161/JAHA.114.001232 – ident: e_1_3_5_7_2 doi: 10.1194/jlr.M050633 – ident: e_1_3_5_45_2 doi: 10.1016/0021-9150(73)90027-0 – ident: e_1_3_5_37_2 doi: 10.1161/ATVBAHA.115.306861 – ident: e_1_3_5_49_2 doi: 10.1016/j.cardiores.2006.09.005 – ident: e_1_3_5_33_2 doi: 10.1016/S0092-8674(03)00154-5 – ident: e_1_3_5_52_2 doi: 10.1097/MOL.0b013e32833ded6a – ident: e_1_3_5_38_2 doi: 10.3171/JNS/2008/109/7/0083 – ident: e_1_3_5_22_2 doi: 10.1074/jbc.272.36.22642 – start-page: 8 volume-title: In: Global Atlas on Cardiovascular Disease Prevention and Control year: 2011 ident: e_1_3_5_2_2 contributor: fullname: Mendis S – ident: e_1_3_5_50_2 doi: 10.1194/jlr.R800032-JLR200 – ident: e_1_3_5_32_2 doi: 10.1161/ATVBAHA.111.235788 – ident: e_1_3_5_59_2 doi: 10.1002/jcb.25074 – ident: e_1_3_5_16_2 doi: 10.1161/01.ATV.19.4.870 – ident: e_1_3_5_27_2 doi: 10.1093/emboj/19.16.4298 – ident: e_1_3_5_41_2 doi: 10.1161/ATVBAHA.110.221440 – ident: e_1_3_5_60_2 doi: 10.1016/S0021-9258(17)31580-6 – ident: e_1_3_5_43_2 doi: 10.3758/BRM.40.3.879 – ident: e_1_3_5_48_2 doi: 10.1161/01.ATV.0000184783.04864.9f – ident: e_1_3_5_42_2 doi: 10.1038/bjc.1995.429 – ident: e_1_3_5_61_2 doi: 10.1016/j.jacc.2011.03.044 |
SSID | ssj0004220 |
Score | 2.469551 |
Snippet | OBJECTIVE—Atherosclerotic lesions contain hypoxic areas, but the pathophysiological importance of hypoxia is unknown. Hypoxia-inducible factor-1α (HIF-1α) is a... Atherosclerotic lesions contain hypoxic areas, but the pathophysiological importance of hypoxia is unknown. Hypoxia-inducible factor-1α (HIF-1α) is a key... Objective— Atherosclerotic lesions contain hypoxic areas, but the pathophysiological importance of hypoxia is unknown. Hypoxia-inducible factor-1α (HIF-1α) is... OBJECTIVEAtherosclerotic lesions contain hypoxic areas, but the pathophysiological importance of hypoxia is unknown. Hypoxia-inducible factor-1α (HIF-1α) is a... |
SourceID | proquest crossref pubmed wolterskluwer |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 1782 |
SubjectTerms | Animals Aorta, Thoracic - metabolism Aorta, Thoracic - pathology Aortic Diseases - genetics Aortic Diseases - metabolism Aortic Diseases - pathology Apolipoproteins E - deficiency Apolipoproteins E - genetics Apoptosis Atherosclerosis - genetics Atherosclerosis - metabolism Atherosclerosis - pathology Bone Marrow Transplantation Cell Differentiation Cell Hypoxia Cell Movement Cells, Cultured Cholesterol - metabolism Disease Models, Animal Disease Progression Foam Cells - metabolism Foam Cells - pathology Genetic Predisposition to Disease Glucose - metabolism Hypoxia-Inducible Factor 1, alpha Subunit - deficiency Hypoxia-Inducible Factor 1, alpha Subunit - genetics Hypoxia-Inducible Factor 1, alpha Subunit - metabolism Inflammation Mediators - metabolism Mice, Inbred C57BL Mice, Knockout Phenotype Plaque, Atherosclerotic Receptors, LDL - deficiency Receptors, LDL - genetics Signal Transduction |
Title | Hypoxia-Inducible Factor-1α Expression in Macrophages Promotes Development of Atherosclerosis |
URI | https://www.ncbi.nlm.nih.gov/pubmed/27444197 https://search.proquest.com/docview/1814666420 |
Volume | 36 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLbKkBATQtwpNwWJPU3Z4jhxmsdualXBOkDKUJ-I7MQRYVpSrY24_Ad-DH-E38Q5sXMZndDgJYrd1pZ8vp5L8p1zCHmVuqkSYBrsIGMQoAQis6VMPJtJLwml9MFmYnLy_JjPTrzXC38xGPzosZaqtdxLvl-aV_I_UoU5kCtmyf6DZNtFYQLuQb5wBQnD9Uoynn1bll9zYWP_jSTHHKhp3T7HpjuHk50DioWMNc-15jPOBfbr-iSwrMO7moYHNz3WUO2VokNYrmAjuOarvu86RvZn3n2G0sEuC2eyGeFD-Jbaaso7tYgS59VSUygLdYYReqeVkUyt1V8kis9id9HyeqrCsD7AChQdqUhXRMDWLuZ3esa0Am-eYlDe0rTACBnNC4DB6mV91WxGGoJhT8_SQLcsMjYby4xdbg842oNx9OFgPBvjcI_he0uns37NG__jt_H05OgojiaL6Bq57oLeQoX55n2v-LzrOk3eFaf7m6te9G02ApZtcutLiRyI1WmdAtFzZKI75LaJQKyxhtNdMlDFPXJjbjgW98nHDVRZDap-_bQ6RFl5YfUQZTWIsnqIssrM-gNRD0g0nUSHM9t04bAT5oSO7aOPKXiqnFHgCdeTrptKBUaUs8DPmEiDbBQI-GsHmeSuyhj4O4o6kmV0lIiUPSRbRVmox8QSEC4nCeUJlZ7HZRIy4cuUpo4acRmwbEh2m-OLl7rWSlzHqJzG5rBxEOvDHpKXzQnHoBLxPZcoVFmtYoqPtTkE1vCdR_ro2_WwIKZHw2BI9i_IItZpx3_Z78kV9ntKbnbgfka21ueVeg5O61q-qKH0G4rinZU |
link.rule.ids | 315,783,787,27936,27937 |
linkProvider | Colorado Alliance of Research Libraries |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Hypoxia-Inducible+Factor-1%CE%B1+Expression+in+Macrophages+Promotes+Development+of+Atherosclerosis&rft.jtitle=Arteriosclerosis%2C+thrombosis%2C+and+vascular+biology&rft.au=Aarup%2C+Annemarie&rft.au=Pedersen%2C+Tanja+X&rft.au=Junker%2C+Nanna&rft.au=Christoffersen%2C+Christina&rft.date=2016-09-01&rft.eissn=1524-4636&rft.volume=36&rft.issue=9&rft.spage=1782&rft.epage=1790&rft_id=info:doi/10.1161%2FATVBAHA.116.307830&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1079-5642&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1079-5642&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1079-5642&client=summon |